![Samir Gharib](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samir Gharib
Finansdirektör/CFO på
SPRUCE BIOSCIENCES, INC.
Förmögenhet: 353 904 $ per 2026-07-31
Profil
Samir M.
Gharib is currently the Director at Cancer CAREpoint since 2017.
Mr. Gharib is also the President & Chief Financial Officer at Spruce Biosciences, Inc. since 2022.
Formerly, Mr. Gharib was Finance Director & Controller at Talon Therapeutics, Inc. from 2012 to 2013.
Mr. Gharib was Managing Director at Benchmark Financial Partners LLC from 2017 to 2018.
Mr. Gharib was Vice President-Finance & Administration at Revance Therapeutics, Inc. from 2013 to 2017.
Mr. Gharib was Chief Financial Officer at Stemedica Cell Technologies, Inc. from 2018 to 2019.
Education includes an undergraduate degree conferred in 2005 and an MBA from Haas School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC. 0,29 % | 2026-03-24 | 8 263 ( 0,29 % ) | 353 904 $ | 2026-07-31 |
Aktiva positioner av Samir Gharib
| Företag | Position | Start |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Finansdirektör/CFO | 2020-05-01 |
Cancer CAREpoint
 Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Direktör/Styrelseledamot | 2017-11-01 |
Tidigare kända positioner av Samir Gharib
| Företag | Position | Slut |
|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Finansdirektör/CFO | 2019-09-01 |
Benchmark Financial Partners LLC | Företagsledare/Principal | 2018-10-01 |
| REVANCE THERAPEUTICS, INC. | Finansdirektör/CFO | 2017-09-01 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Finansdirektör/CFO | 2013-09-01 |
Samir Gharibs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
83
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders | Health Technology |
Cancer CAREpoint
Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Commercial Services |
Benchmark Financial Partners LLC |
